tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
INMB is currently covered by 3 analysts with an average price target of $7.76. This is a potential upside of $5.91 (319.46%) from yesterday's end of day stock price of $1.85.
INmune Bio's activity chart (see below) currently has 14 price targets and 15 ratings on display. The stock rating distribution of INMB is 66.67% BUY, 16.67% SELL and 16.67% HOLD.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 140.5 days.
Highest price target for INMB is $8, Lowest price target is $0.6, average price target is $4.3.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 01-Jul-2025. First documented stock forecast 17-Dec-2019.
Currently out of the existing stock ratings of INMB, 4 are a BUY (66.67%), 1 are a SELL (16.67%), 1 are a HOLD (16.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$8
$6.14 (330.11%)
$30
3 months 15 days ago
(01-Jul-2025)
0/2 (0%)
$5.64 (238.98%)
Hold
$14
3 months 16 days ago
(30-Jun-2025)
1/2 (50%)
$8.52 (155.47%)
631
Sell
$0.6
$-1.26 (-67.74%)
$23
3 months 16 days ago
(30-Jun-2025)
0/4 (0%)
$-1.49 (-71.29%)
Hold
$7
$5.14 (276.34%)
$20
3 years 4 months 23 days ago
(23-May-2022)
1/2 (50%)
$1.52 (27.74%)
13
Buy
$34
$32.14 (1727.96%)
$29
4 years 3 months 3 days ago
(13-Jul-2021)
0/2 (0%)
$11.04 (48.08%)
What is INMB (INmune Bio) average time for price targets to be met?
Which analyst has the current highest performing score on INMB (INmune Bio) with a proven track record?
Which analyst has the current lower performing score on INMB (INmune Bio) with a proven track record?
Which analyst has the most public recommendations on INMB (INmune Bio)?
Which analyst is the currently most bullish on INMB (INmune Bio)?
Which analyst is the currently most reserved on INMB (INmune Bio)?
